Clinical Trial Update: Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RZ-629 in Healthy Subjects and T2D [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of RZ-629 in healthy subjects and individuals with T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• RZ-629

Snippet

Sponsor: Rezubio Pharmaceuticals Co., Ltd. | Conditions: Diabetes | Phase 1 | Status: RECRUITING